FindTrial
Sign In

Effect of Takrarishta on Irritable Bowl Syndrome

A single arm, open label clinical study to assess Takrarishta effectiveness on gut microbiota in relation to irritable bowel syndrome: A pilot study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067261
Enrollment
12
Registered
2024-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

None listed

Sponsors

Bhimashankar Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Any gender 2) Any age range 21 and 50 3) Patient in a raw experiencing the primary symptoms of abdominal pain, flatulence, alterated bowel habit, change in frequency of bowel 4) individuals who exhibit the following symptoms: Mandagni and Mrudu Kosht

Exclusion criteria

Exclusion criteria: 1) the participant lack of consent to continue their participation in study 2) Identification of any known gastrointestinal condition such as cancer hepatic failure IBD and renal insuffieucency 3) Patient incapacity to complete all study phases ,age under 18 4) pregnent women, 5) chronic history of medication

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Takrarishta in the stool culture and  sensitivity of colony count reduction in IBS patients. Timepoint: 14 days—

Secondary

MeasureTime frame
Adverse effect or any event of takrarishta on Irritable Bowl SyndromeTimepoint: 14 days—

Countries

India

Contacts

Public ContactDr Vikrant Pawar

Bhimashankar Ayurved College Wadgaon (Kashimbeg) Manchar,pune

drvikrantpawar@gmail.com9970691490

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026